Shares have been on the move with the stock up 1.8% over the past month. The stock hit a new 52-week high of $34.4 in the previous session. HashiCorp, Inc. has gained 0.2% since the start of the year ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...

HashiCorp (HCP) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues. As the Q3 earnings season comes to a close ...

HashiCorp, Inc. (HCP) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates ...

Check the time stamp on this data. Updated AI-Generated Signals for Hashicorp Inc. (HCP) available here: HCP.

HashiCorp, Inc. (NASDAQ:HCP – Get Free Report)’s share price reached a new 52-week high during trading on Friday . The stock traded as high as $34.39 and last traded at $34.38, with a volume of ...

New research reveals some significant imbalances between healthcare professionals' (HCP) demand and industry's provision of medical information, based on content types, channels and format.

Shares of HashiCorp, Inc. (NASDAQ:HCP – Get Free Report) have received a consensus recommendation of “Hold” from the fourteen research firms that are currently covering the company, Marketbeat Ratings ...

Headquartered in Irvine, CA, HCP, Inc. is a real estate investment trust (REIT) in the United States that acquires, develops, manages, sells and leases a diverse portfolio of healthcare real ...